FORGE HEALTH GROUP — All Prescriptions & Medications — Page 10
Practice Code: C88008 | SHEFFIELD, S3 9DL
Showing results 451-500 of 716
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 41 | 4,720 | £145 | +142.6% ▲ | |
| Ethosuximide | 40 | 20.6K | £19.8K | +171.2% ▲ |
| Alverine citrate | 39 | 2,938 | £112 | -5.8% ▼ |
| Ondansetron hydrochloride | 39 | 2,376 | £851 | -19.6% ▼ |
| Levonorgestrel | 39 | 39 | £3.2K | +3.3% ▲ |
| Duloxetine hydrochloride | 39 | 1,680 | £376 | -23.9% ▼ |
| Azelastine hydrochloride | 39 | 312 | £238 | +228.1% ▲ |
| Pimecrolimus | 39 | 1,590 | £968 | +130.3% ▲ |
| 39 | 1,161 | £2.8K | -2.2% ▼ | |
| Capsaicin | 38 | 2,025 | £665 | +381.4% ▲ |
| Acetazolamide | 38 | 2,118 | £215 | +75.4% ▲ |
| Other sunscreening preparations | 38 | 4,550 | £456 | +384.9% ▲ |
| Ivermectin | 37 | 1,710 | £992 | +74.0% ▲ |
| 37 | 5,210 | £822 | +277.7% ▲ | |
| Guanfacine | 36 | 1,092 | £2.2K | +40.1% ▲ |
| Methotrexate | 36 | 141 | £2.2K | +20.7% ▲ |
| Exemestane | 36 | 1,052 | £186 | +10.8% ▲ |
| 36 | 2,515 | £4.4K | -3.0% ▼ | |
| 36 | 3,520 | £120 | -57.7% ▼ | |
| Glycopyrronium bromide | 35 | 3,900 | £3.4K | +70.5% ▲ |
| 35 | 2,427 | £203 | +4.9% ▲ | |
| 35 | 360 | £987 | -26.8% ▼ | |
| 35 | 1,350 | £5.4K | -22.6% ▼ | |
| Ipratropium bromide | 34 | 73 | £185 | +18.3% ▲ |
| Celecoxib | 34 | 2,696 | £154 | -48.5% ▼ |
| Acetic acid | 34 | 190 | £178 | +193.5% ▲ |
| Benzoyl peroxide | 34 | 1,410 | £243 | +141.3% ▲ |
| Calcium acetate | 33 | 4,068 | £427 | +78.3% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 32 | 960 | £2.3K | +29.0% ▲ |
| 32 | 84 | £524 | -10.5% ▼ | |
| Colistimethate sodium | 31 | 1,828 | £4.5K | +174.2% ▲ |
| Ready to serve infant formula, high energy (0913104) | 31 | 239.9K | £3.6K | +180.6% ▲ |
| 31 | 626 | £322 | +69.1% ▲ | |
| Phosphates (Rectal) | 30 | 463 | £14.6K | +145.4% ▲ |
| Norethisterone | 30 | 2,856 | £69 | +114.5% ▲ |
| Febuxostat | 30 | 686 | £80 | -19.7% ▼ |
| Diclofenac diethyl | 30 | 3,000 | £143 | -91.6% ▼ |
| Hydrocortisone acetate | 30 | 960 | £183 | -54.6% ▼ |
| 30 | 243 | £840 | -23.7% ▼ | |
| 30 | 87 | £1.4K | +129.5% ▲ | |
| 30 | 340 | £1.0K | +47.3% ▲ | |
| 30 | 1,422 | £507 | -62.7% ▼ | |
| Prucalopride | 29 | 812 | £331 | -25.5% ▼ |
| Nebivolol | 29 | 812 | £93 | -72.6% ▼ |
| Moxonidine | 29 | 1,624 | £228 | -47.9% ▼ |
| Acrivastine | 29 | 2,118 | £621 | +135.4% ▲ |
| Travoprost | 29 | 73 | £213 | -38.5% ▼ |
| Azelastine hydrochloride | 29 | 612 | £282 | +158.7% ▲ |
| 29 | 466 | £53 | -2.9% ▼ | |
| 29 | 5,800 | £103 | +857.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.